目录号 | 产品详情 | 靶点 | |
---|---|---|---|
T13514 | Others | ||
5-MethoxyPinocembroside 是一种黄酮类天然产物,存在于辣木 Moringa oleifera 的叶子中。 | |||
T10183 | Others | ||
6-Methoxytricin is a flavonoid isolated from Artemisia iwayomogi. It is an inhibitor on aldose reductase (AR) and advanced glycation endproduct (AGE) formation activities (IC50s: 30.29 μM and 134.88 μM). 6-Methoxytricin has potential as an anti-diabetic c | |||
TN1082 | |||
Apigenin 7-O-malonylglucoside (Apigenin 7-O-(6''-O-malonylglucoside)) 存在于菊花中,是一种黄酮,也是一种糖苷。 | |||
T5S1526 | Others | ||
Apigenin-7-O-(2G-rhamnosyl)gentiobioside 是一种黄酮类苷化合物,从Lonicera gracilipes var. glandulosa 中提取得到。 | |||
T4130 | Others | ||
Complanatuside (Complanatoside) 是一种黄酮类化合物,存在于中药沙苑子中。 | |||
T3325 | Estrogen Receptor/ERR Estrogen/progestogen Receptor | ||
Liquiritigenin (4',7-Dihydroxyflavanone) 是一种黄烷酮,从甘草中分离得到,是高度选择性的雌激素受体β 激动剂,用于活化 ERE tk-Luc 的 EC50值为36.5 nM。 | |||
T4S0217 | TNF NF-κB | ||
Homoplantaginin 是来自中药荔枝草的一种类黄酮,具有抗炎和抗氧化活性。 | |||
TN7233 | Others | ||
Pseudobaptigenin (Psi-baptigenin) 是一种异黄酮,是一种黄酮类脂质分子,是在Pterocarpus marsupium、Dalbergia spruceana 中发现的一种天然产品。 | |||
T8158 | Others | ||
Tilianin 是一种广泛存在于多种药用植物中的活性黄酮类苷,具有降压、保护心肌、降血脂、抗糖尿病、抗炎、抗氧化等作用。 | |||
TN1039 | Endogenous Metabolite Immunology/Inflammation related | ||
Tamarixetin (4'-O-Methyl Quercetin) 是一种槲皮素的天然类黄酮衍生物,具有抗氧化、抗炎作用,能够防止心肌肥厚。 |
目录号 | 产品名/同用名 | 种属 | 表达系统 | ||
---|---|---|---|---|---|
TMPY-01579 | GBA3 Protein, Human, Recombinant (His) | Human | Baculovirus-Insect Cells | ||
Cytosolic beta-glucosidase, also known as Cytosolic beta-glucosidase-like protein 1, GBA3, CBG and CBGL1 is a cytoplasm protein which belongs to theglycosyl hydrolase 1 family and Klotho subfamily. GBA3 / CBGL1 is a glycosidase probably involved in the intestinal absorption and metabolism of dietary flavonoid glycosides. GBA3 / CBGL1 is present in small intestine (at protein level). GBA3 / CBGL1 is expressed in liver, small intestine, colon, spleen and kidney. GBA3 / CBGL1 is down-regulated in renal cell carcinomas and hepatocellular carcinomas. GBA3 / CBGL1 is able to hydrolyze a broad variety of glycosides including phytoestrogens, flavonols, flavones, flavanones and cyanogens. GBA3 / CBGL1 possesses beta-glycosylceramidase activity and may be involved in a nonlysosomal catabolic pathway of glycosylceramide.
|
|||||
TMPY-02041 | Cortisol Binding Globulin Protein, Human, Recombinant (His) | Human | HEK293 | ||
Corticosteroid-binding globulin (CBG), also known as SerpinA6, is a non-inhibitory member of the serine proteinase inhibitor (serpin) superfamily. It is the high-affinity transport protein for glucocorticoids in vertebrate blood. CBG is specifically cleaved by this protease at a precise site close to its carboxy-terminus. This induces a conformation change and disrupts the binding between glucocorticoids and CBG, and promotes a significant and local release of glucocorticoids (over 90% of them are bound to CBG in human plasma). In this context, CBG directs glucocorticoids to sites of inflammation, and plays in consequence a crucial role in efficient glucocorticoid action in physiology. The SerpinA6 protein is mainly secreted by the liver. This negative acute phase protein regulates free cortisol levels in the blood and distributes cortisol to its target tissues. SerpinA6 deficiency is an extremely rare hereditary disorder characterized by reduced corticosteroid-binding capacity with normal or low plasma corticosteroid-binding globulin concentration, and normal or low basal cortisol levels associated with hypo-/hypertension and muscle fatigue. There are three heritable, human CBG gene mutations that can reduce CBG-cortisol binding affinity and/or reduce circulating CBG levels.
|
|||||
TMPY-06702 | Cortisol Binding Globulin Protein, Mouse, Recombinant (His & Avi), Biotinylated | Mouse | HEK293 | ||
Corticosteroid-binding globulin (CBG), also known as SerpinA6, is a non-inhibitory member of the serine proteinase inhibitor (serpin) superfamily. It is the high-affinity transport protein for glucocorticoids in vertebrate blood. CBG is specifically cleaved by this protease at a precise site close to its carboxy-terminus. This induces a conformation change and disrupts the binding between glucocorticoids and CBG, and promotes a significant and local release of glucocorticoids (over 90% of them are bound to CBG in human plasma). In this context, CBG directs glucocorticoids to sites of inflammation, and plays in consequence a crucial role in efficient glucocorticoid action in physiology. The SerpinA6 protein is mainly secreted by the liver. This negative acute phase protein regulates free cortisol levels in the blood and distributes cortisol to its target tissues. SerpinA6 deficiency is an extremely rare hereditary disorder characterized by reduced corticosteroid-binding capacity with normal or low plasma corticosteroid-binding globulin concentration, and normal or low basal cortisol levels associated with hypo-/hypertension and muscle fatigue. There are three heritable, human CBG gene mutations that can reduce CBG-cortisol binding affinity and/or reduce circulating CBG levels.
|
|||||
TMPY-05099 | GBA/glucocerebrosidase Protein, Human, Recombinant (His) | Human | HEK293 | ||
Mutations in the GBA gene, encoding the lysosomal hydrolase glucocerebrosidase (GCase), are the most common known genetic risk factor for Parkinson's disease (PD) and dementia with Lewy bodies (DLB). ASAH1 (acid ceramidase 1) and GBA2 (glucocerebrosidase 2) enzymes that mediate glucosylsphingosine production and metabolism are attractive therapeutic targets for treating mutant GBA-associated PD.
|
|||||
TMPY-02107 | Cortisol Binding Globulin Protein, Mouse, Recombinant (His) | Mouse | HEK293 | ||
Corticosteroid-binding globulin (CBG), also known as SerpinA6, is a non-inhibitory member of the serine proteinase inhibitor (serpin) superfamily. It is the high-affinity transport protein for glucocorticoids in vertebrate blood. CBG is specifically cleaved by this protease at a precise site close to its carboxy-terminus. This induces a conformation change and disrupts the binding between glucocorticoids and CBG, and promotes a significant and local release of glucocorticoids (over 90% of them are bound to CBG in human plasma). In this context, CBG directs glucocorticoids to sites of inflammation, and plays in consequence a crucial role in efficient glucocorticoid action in physiology. The SerpinA6 protein is mainly secreted by the liver. This negative acute phase protein regulates free cortisol levels in the blood and distributes cortisol to its target tissues. SerpinA6 deficiency is an extremely rare hereditary disorder characterized by reduced corticosteroid-binding capacity with normal or low plasma corticosteroid-binding globulin concentration, and normal or low basal cortisol levels associated with hypo-/hypertension and muscle fatigue. There are three heritable, human CBG gene mutations that can reduce CBG-cortisol binding affinity and/or reduce circulating CBG levels.
|
|||||
TMPY-05329 | Cortisol Binding Globulin Protein, Human, Recombinant (His & Avi), Biotinylated | Human | HEK293 | ||
Corticosteroid-binding globulin (CBG), also known as SerpinA6, is a non-inhibitory member of the serine proteinase inhibitor (serpin) superfamily. It is the high-affinity transport protein for glucocorticoids in vertebrate blood. CBG is specifically cleaved by this protease at a precise site close to its carboxy-terminus. This induces a conformation change and disrupts the binding between glucocorticoids and CBG, and promotes a significant and local release of glucocorticoids (over 90% of them are bound to CBG in human plasma). In this context, CBG directs glucocorticoids to sites of inflammation, and plays in consequence a crucial role in efficient glucocorticoid action in physiology. The SerpinA6 protein is mainly secreted by the liver. This negative acute phase protein regulates free cortisol levels in the blood and distributes cortisol to its target tissues. SerpinA6 deficiency is an extremely rare hereditary disorder characterized by reduced corticosteroid-binding capacity with normal or low plasma corticosteroid-binding globulin concentration, and normal or low basal cortisol levels associated with hypo-/hypertension and muscle fatigue. There are three heritable, human CBG gene mutations that can reduce CBG-cortisol binding affinity and/or reduce circulating CBG levels.
|
|||||
TMPY-00027 | GSTT2B Protein, Human, Recombinant (His) | Human | HEK293 | ||
GSTT2B Protein, Human, Recombinant (His) is expressed in HEK293 with His tag. The predicted molecular weight is 29 kDa. Accession number: P0CG29
|